Clinical Trial Update: ARI103094-Follow-Up Study for REDUCE Study Subjects

View source ↗

Summary

This is a clinical trial update announcing the completion of the ARI103094 follow-up study for REDUCE subjects with prostate cancer. The sponsor listed is Glaxo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• ARI103094

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neoplasms, Prostate | Status: COMPLETED